Association between serum alkaline phosphatase and resistance to erythropoiesis stimulating agents in chronic kidney disease: a post-hoc analysis of the HERO trial

Johnson, D.W.Pascoe, E.M.Badve, S.V.Dalziel, K.Cass, A.Clarke, P.Ferrari, P.Mcdonald, S.P.Morrish, A.T.Pedagogos, E.Perkovic, V.Scaria, A.Walker, R.Vergara, L.A.Hawley, C.M.2017-07-132017-07-132016Nephrology, 2016, vol.19, iss.S4, pp.29-291320-53581440-1797http://hdl.handle.net/2440/106465Abstract not availableen© 2014 The Authors.HERO Study Collaborative GroupAssociation between serum alkaline phosphatase and resistance to erythropoiesis stimulating agents in chronic kidney disease: a post-hoc analysis of the HERO trialConference item003007234310.1111/nep.12301000339715700058361564Mcdonald, S.P. [0000-0001-6103-1386]